Letters in Drug Design & Discovery

G. Perry
University of Texas
San Antonio, TX
Email: lddd@benthamscience.org


Design, Synthesis and Biological Evaluation of Novel Aminosaccharide Derivatives of Combretastatin A-4

Author(s): Yan Tang, Zhewei Tu, Jing Sun, Xiong Zhu, Kun Liu, Shuying He, Yungen Xu.


Combretastatin A-4 (CA-4), a natural vascular disrupting agent (VDA) with potent anti-cancer activity, is a promising lead compound in drug discovery. In view of the potential application of carbohydrates in medicinal chemistry, we designed and synthesized sixteen novel CA-4 aminosaccharide derivatives. In vitro anti-proliferative studies showed that compounds 7a and 7c significantly inhibited the growth of human umbilical vein endothelia cells (HUVEC) and other four cancer cell lines. Besides, preliminary structure-activity relationship (SAR) was summarized.

Keywords: Anti-cancer agent, Aminosaccharide, Combretastatin A-4 (CA-4), Vascular disrupting agent (VDA), Structural modification, Human umbilical vein endothelia cells (HUVEC).

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Year: 2013
Page: [935 - 941]
Pages: 7
DOI: 10.2174/15701808113109990024
Price: $58